[PLX] QoQ Quarter Result on 30-Sep-2015 [#Q3]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
09-Nov-2015
Financial Year
2015
Quarter
30-Sep-2015 [#Q3]
Profit Trend
QoQ- 24.67%
YoY- 52.31%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Revenue 1,769 679 -11,195 5,846 4,616 5,097 1,384 17.79%
PBT -10,736 -8,526 -12,419 -3,820 -5,071 -5,972 -8,469 17.14%
Tax 213 314 -85,260 17 43 28 57 141.00%
NP -10,853 -8,598 72,900 -3,820 -5,071 -5,972 -8,469 17.99%
Tax Rate - - - - - - - -
Total Cost 12,622 9,277 -84,095 9,666 9,687 11,069 9,853 17.97%
Ratio Analysis
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
NP Margin -613.51 -1,266.27 -651.18 -65.34 -109.86 -117.17 -611.92 0.17%
Per Share
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
EPS -0.11 -0.09 7.31 -0.04 -0.05 -0.06 -0.91 -75.58%
EPS Diluted -0.11 -0.09 7.31 -0.04 -0.05 -0.06 -0.91 -75.58%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.